Calls from inside the house: FTC commissioners criticize report on PBMs

After the Federal Trade Commission released its report highlighting the “enormous power” pharmacy benefit managers have over drug pricing and access, agency Commissioner Melissa Holyoak, criticized the report and its findings in a dissenting statement.